Calcipotriol (MC 903): Pharmacokinetics in rats and biological activities of metabolites: A comparative study with 1,25(OH)2D3
- 1 June 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (11) , 1601-1606
- https://doi.org/10.1016/0006-2952(91)90160-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- In vitro metabolism of Calcipotriol (MC 903), a vitamin D analogueBiochemical Pharmacology, 1990
- Treatment of Psoriasis by the Topical Application of the Novel Cholecalciferol Analogue Calcipotriol (MC 903)Archives of Dermatology, 1989
- Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through the C-24 oxidation pathwayBiochemistry, 1989
- Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind studyBritish Journal of Dermatology, 1988
- Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivoBiochemical Pharmacology, 1988
- Effect of Dietary Calcium, Phosphate and Vitamin D Deprivation on the Pharmacokinetics of 1,25-Dihydroxyvitamin D3in the RatHormone and Metabolic Research, 1987
- Synthesis of mc 903, a biologically active vitamin D metabolite analogueTetrahedron, 1987
- Effect of dietary mineral and vitamin D content and parathyroidectomy on the plasma disappearance rate of 1,25‐dihydroxy vitamin D3 in ratsBiopharmaceutics & Drug Disposition, 1985
- 1α, 25-dihydroxycholecalciferol and human histiocytic lymphoma cell line (U-937): The presence of receptor and inhibition of proliferationLife Sciences, 1984
- A new method for determining micro quantities of calcium in biological materialsAnalytical Biochemistry, 1967